Solid Biosciences (SLDB) Accumulated Depreciation & Amortization (2017 - 2024)
Solid Biosciences (SLDB) has disclosed Accumulated Depreciation & Amortization for 8 consecutive years, with $13.1 million as the latest value for Q1 2024.
- Quarterly Accumulated Depreciation & Amortization rose 20.22% to $13.1 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $13.1 million through Mar 2024, up 20.22% year-over-year, with the annual reading at $12.7 million for FY2023, 16.24% up from the prior year.
- Accumulated Depreciation & Amortization hit $13.1 million in Q1 2024 for Solid Biosciences, up from $12.7 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $13.1 million in Q2 2022 to a low of $5.8 million in Q1 2020.
- Historically, Accumulated Depreciation & Amortization has averaged $10.5 million across 5 years, with a median of $10.9 million in 2021.
- Biggest five-year swings in Accumulated Depreciation & Amortization: soared 125.12% in 2020 and later fell 13.61% in 2022.
- Year by year, Accumulated Depreciation & Amortization stood at $8.7 million in 2020, then soared by 33.83% to $11.7 million in 2021, then fell by 6.05% to $11.0 million in 2022, then increased by 16.24% to $12.7 million in 2023, then increased by 2.49% to $13.1 million in 2024.
- Business Quant data shows Accumulated Depreciation & Amortization for SLDB at $13.1 million in Q1 2024, $12.7 million in Q4 2023, and $12.1 million in Q3 2023.